• <rp id="0gkl0"></rp>
    <tt id="0gkl0"><form id="0gkl0"></form></tt>
    <tt id="0gkl0"><form id="0gkl0"><label id="0gkl0"></label></form></tt>
    <rt id="0gkl0"><meter id="0gkl0"></meter></rt>
      <cite id="0gkl0"></cite>
      <rt id="0gkl0"></rt>
    1. <rt id="0gkl0"></rt>
      <b id="0gkl0"><form id="0gkl0"></form></b>

    2. <b id="0gkl0"><form id="0gkl0"><del id="0gkl0"></del></form></b>
      <cite id="0gkl0"><tbody id="0gkl0"><delect id="0gkl0"></delect></tbody></cite>
      <b id="0gkl0"><tbody id="0gkl0"></tbody></b>
      <cite id="0gkl0"><noscript id="0gkl0"></noscript></cite>
      <u id="0gkl0"><form id="0gkl0"><delect id="0gkl0"></delect></form></u>

        Creating value together

        Partnering with us

        From prevention to treatment, we transform scientific innovation into healthcare solutions in Human Vaccines, Rare Diseases, Multiple Sclerosis & Neuroscience, Oncology, Immunology, Diabetes & Cardiovascular, Digital Technology, Drug Discovery & Biologics, and Consumer Healthcare. Our diversity and global reach is supported by our strong presence in Mature and Emerging Markets.

        An open partnering model

        Sanofi R&D vision & strategy

        ampoule
        Vision
        • An industry innovation leader bringing transformative solutions to patients
        partnering
        Strategy
        • Allocate resources to priority therapeutic areas
        • Leverage multiple therapeutic modalities
        • Accelerate early development
        partnering
        Long-term objectives
        • 80% first or best in class
        • 70% biologics
        • 70% internally derived
        investment
        <br><br><br>R&D investment ~€6bn<sup>(2)</sup>

        Partnering strategy

        Global Business Units


        Value creation through partnerships

        We believe that Alliance Management is the keystone of any sound and successful collaboration. For this reason, we have a dedicated team of Alliance Managers, working across the globe to fulfill the mission of maximizing the value through collaborative engagement, management of risk, actionable assessment and agile governance..

        What we are looking for?

        As a trusted partner in the healthcare journey, we understand science and embrace innovation. Working across the drug discovery continuum from prevention through cures, we are eager to learn more about your advances in early- to latestage development. Our partnering brochure will add more insight about our major therapeutic areas and flexible approach to deal making.

        Contact us

        SPECIALTY CARE (SANOFI GENZYME)
        MS/NEUROLOGY, RARE BLOOD DISORDERS, RARE DISEASES
        Brian BRONK - brian.bronk@sanofi.com
        ONCOLOGY & IMMUNOLOGY
        Michael PALLADINETTI - michael.palladinetti@sanofi.com 

        CONSUMER HEALTHCARE
        Oliver FREICHEL – oliver.freichel@sanofi.com

        OUT-LICENSING
        Matthieu LEBRUN - matthieu.lebrun@sanofi.com

        SANOFI PASTEUR
        Donna MARTIN - donna.martin@sanofi.com 
        R&D Sanofi Pasteur
        Roman CHICZ - roman.chicz@sanofi.com

        CHINA & EMERGING MARKETS
        Matthieu MERLIN - matthieu.merlin@sanofi.com
        Latin America
        Alexandre BOGGIO - alexandre.boggio@sanofi.com
        Japan, Pacific
        Masanori SATO – masanori.sato@sanofi.com  
        Africa, Middle East, Eurasia & South Asia
        Eric SOL - eric.sol@sanofi.com

        INNOVATIVE TECHNOLOGIES
        Shiv KRISHNAN – shiv.krishnan@sanofi.com

        DIGITAL
        Rachel SHA – rachel.sha@sanofi.com

        Manufacturing and supply

        Sanofi Active Ingredient Solutions: An organization fully dedicated to third party Active Pharmaceutical Ingredients activities

        Our Mission

        We work passionately, every day, to develop, manufacture and supply active pharmaceutical ingredients for your markets across the world.

        We leverage our industrial expertise and experience to meet the highest quality requirements while focusing permanently on your satisfaction.

        Sanofi Active Ingredient Solutions offers a broad range of solutions to third parties:

        • A portfolio of more than 120 active pharmaceutical ingredients available for human and animal health
        • A contract development and manufacturing organization

        This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

        Click here for more information on cookies
        OK
        亚洲伊人色综网